Medis ehf.

Medis is a leader in pharmaceutical development and out licensing, offering a broad portfolio of quality pharmaceutical products and comprehensive registration dossiers and intellectual property since 1985. Medis is a powerful partner with a proven track record in securing regulatory approval prior to patent expiries, and has obtained marketing authorizations in over 140 countries to date. We out-license products from the pipeline of our parent company, Teva. Medis ehf is 100% owned by Teva Pharmaceutical Industries Ltd (NYSE, TASE: TEVA).

We offer:
•Dossiers with product supply for generic products for all major therapeutic categories
•Full launch coordination to ensure customers timely Day-1 launches to market
•High quality generic products and registration dossiers according to current EU standards (CTD)
•Extensive generic portfolio with more than 150 dossiers and around 800 available licenses
•Single-point-of-contact...